1. Friday May 25, 2018
      Home > BUSINESS
      Text:| Print|

      Bear bile IPO bid gets little authoritative support

      2012-03-12 14:27 Xinhua     Web Editor: Zhang Chan comment

      After weeks of criticism, Chinese bear bile producer Guizhentang faces a bumpier path for going public, as discussion over its listing attempt has continued to sizzle at the country's annual legislative session but little support has been found.

      Xiao Wei, a Chinese lawmaker and an authority in the pharmaceutical industry, voiced straight opposition to the initial public offering (IPO) of Guizhentang Pharmaceutical Co. Ltd, the East China company that harvests bile from live bears to use in its products.

      It would be "inappropriate" for pharmaceutical companies that turn a profit selling bear bile to seek a listing in the capital market, said Xiao, who is a member of the Chinese Pharmacopoeia Commission and head of a state key laboratory for traditional Chinese medicine (TCM).

      "It could mean that they will extract more bile from live bears," said Xiao, who is also a deputy of the National People's Congress, China's top legislature.

      For nearly 3,000 years, bear bile has been used as an ingredient in TCM to cure eye and liver ailments.

      "I only approve of the use of bear bile in the treatment of very rare or acute diseases, but I do not think it can be used that much in common diseases," he said, adding that he believes the medical value of bear bile is "complicated and irreplaceable."

      Guizhentang has already established an industry chain, as it feeds bears for their bile, which is against international animal protection conventions, he said.

      Guizhentang has been under fire for weeks since it was found to have resumed a plan to go public to expand its bile production. The company's last IPO attempt in February 2011 floundered amid fierce public opposition.

      The bear bile producer allowed more than 100 reporters to visit its bear farm in February amid protests from the public and animal welfare activists, but this has done little to help quell criticism.

      In response to public concern, Chinese securities authorities said they have "noticed" the recent debates over bear bile products and are soliciting opinions from relevant departments on the matter.

      Zhu Congjiu, assistant chairman of the China Securities Regulatory Commission (CSRC), said the CSRC will examine Guizhentang's IPO plan after seeking opinions on whether the listing will be in line with China's industrial policies.

      In response to a similar question, Chinese Health Minister Chen Zhu said human beings should follow the principle of sustainable use of natural resources and protection over bio-diversity.

      "We have ethical principles that human beings and nature should maintain a compatible relationship, and that animals, including experimental ones, should be strictly protected," Chen said while commenting on the bear bile extraction.

      "When humans and nature have a conflict of interests, we tend to choose the lesser of two evils," he said.

      But some showed a more tough stance by calling for legislation to ban bile extraction from live bears.

      "I have been in tears since I heard of the extraction on my plane back from Hong Kong," said Feng Jicai, a well-known Chinese writer and vice-chairman of China Federation of Literary and Art Circles.

      "It is not a question whether extracting bile from live bears should be banned," said Feng, who is also a member of the National Committee of the Chinese People's Political Consultative Conference, China's top political advisory body.

      Wang Guoqiang, vice health minister and director of the State Administration of TCM, said Chinese authorities are promoting research to find for alternatives to animal-derived drugs.

      Wang said TCM authorities do not oppose public discussion on the issue, but he called on the public to approach the debate from more rational perspectives, since a substitute for bear bile has yet to be found and more work needs to be done to improve the technologies.

      Comments (0)

      Copyright ©1999-2011 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.

      主站蜘蛛池模板: 妻子5免费完整高清电视| 日韩精品免费在线视频| 成年美女黄网站18禁免费| 亚洲首页在线观看| 57pao国产成视频免费播放 | 亚洲日韩国产精品乱| xxxxx做受大片视频免费| 中文字幕亚洲日本岛国片| 国产在线精品一区免费香蕉| 亚洲欧洲自拍拍偷午夜色无码| 永久免费av无码入口国语片| 久久久综合亚洲色一区二区三区| 精品无码人妻一区二区免费蜜桃 | 伊伊人成亚洲综合人网7777| 你懂的免费在线观看| 久久久久久久亚洲Av无码| 色片在线免费观看| 在线观看亚洲专区| 亚洲香蕉成人AV网站在线观看| 日本视频免费高清一本18| 亚洲三级中文字幕| 免费一级做a爰片性色毛片| 中文字幕在线免费视频| 久久亚洲AV无码精品色午夜麻豆| 成人性生交大片免费看无遮挡| 在线亚洲精品视频| 亚洲福利视频一区| 最近的免费中文字幕视频| 成人午夜影视全部免费看| 久久久久亚洲av无码专区| 成人在线免费观看| 久久久久久久久久久免费精品| 亚洲另类自拍丝袜第1页| 免费日本黄色网址| 午夜免费福利片观看| 老司机亚洲精品影院在线观看| 亚洲av永久无码精品秋霞电影影院| 国产h视频在线观看免费| 久久久WWW成人免费精品| 亚洲国产区男人本色在线观看| 亚洲伊人成无码综合网|